Foley & Lardner LLP partners Alexis Bortniker and Adria Warren were announced as members of HMP Global’s Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx) 2023 Leadership Congress.
The annual Congress hosts the conversation and deliberations among stakeholders who have interest, influence, and impact on the evolving business models of cancer care, with a focus on improving outcomes for patients.
This year’s Congress creates an interactive environment for cancer care stakeholders to explore and share practical approaches to issues that are relevant to them today including enterprise viability during a time of consolidation, resource constraints, worker shortages, and leveraging data to inform clinical and business decisions.
The 2023 Congress will be held October 6-8 in Boston and is the official meeting of the Journal of Clinical Pathways, a peer-reviewed journal that works to advance the discussion of clinical pathways to provide high-quality, cost-effective care.
